Cipher Pharmeuticals

CPH-T

Analysis and Opinions about CPH-T

Signal
Opinion
Expert
BUY
BUY
March 24, 2015

Has some zip to it. Long term it should do well.

Show full opinionHide full opinion

Has some zip to it. Long term it should do well.

DON'T BUY
DON'T BUY
February 5, 2015

He likes this and has a fairly large position, but his average cost is $7. The challenge going forward as it goes higher, is that they have a very high dependence on a single product. The challenge over time is to get diversification into their portfolio. He thinks this can definitely go higher, but some of the smaller names such as Nobilis (NHC-T), Patient Home Monitoring (PHM-X) and CRH Medical (CRH-T) would be better. If you had $3000, you could spread it over these 3 as there is still a lot of growth, but he wouldn’t have exposure to one individual name.

Show full opinionHide full opinion

He likes this and has a fairly large position, but his average cost is $7. The challenge going forward as it goes higher, is that they have a very high dependence on a single product. The challenge over time is to get diversification into their portfolio. He thinks this can definitely go higher, but some of the smaller names such as Nobilis (NHC-T), Patient Home Monitoring (PHM-X) and CRH Medical (CRH-T) would be better. If you had $3000, you could spread it over these 3 as there is still a lot of growth, but he wouldn’t have exposure to one individual name.

HOLD
HOLD
December 24, 2014

He would recommend the 3 Top Picks for this show over this stock, because they are just getting going. All 3 of them are related to the Bio/medical/Pharma world.

Show full opinionHide full opinion

He would recommend the 3 Top Picks for this show over this stock, because they are just getting going. All 3 of them are related to the Bio/medical/Pharma world.

COMMENT
COMMENT
December 11, 2014

This looks like it could be breaking out. Everything is going well with its products and its relationship with Dr. Reddy’s (RDY-N). Good management.

Show full opinionHide full opinion

This looks like it could be breaking out. Everything is going well with its products and its relationship with Dr. Reddy’s (RDY-N). Good management.

Showing 16 to 19 of 19 entries